Invention Grant
- Patent Title: Triazine based radiopharmaceuticals and radioimaging agents
-
Application No.: US15492933Application Date: 2017-04-20
-
Publication No.: US10086096B2Publication Date: 2018-10-02
- Inventor: John W. Babich , Craig Zimmerman , John L. Joyal , Genliang Lu
- Applicant: Molecular Insight Pharmaceuticals, Inc.
- Applicant Address: US NY New York
- Assignee: Molecular Insight Pharmaceuticals, Inc.
- Current Assignee: Molecular Insight Pharmaceuticals, Inc.
- Current Assignee Address: US NY New York
- Agency: Foley & Lardner LLP
- Agent Gilberto M. Villacorta; Jeffrey R. Lomprey
- Main IPC: A61K49/00
- IPC: A61K49/00 ; A61K51/04 ; C07D403/14 ; C07D413/14 ; C07F5/00 ; A61B6/00 ; C07D401/14
Abstract:
Metal complexes including a radionuclide and a compound of Formula I and Formula II are potent inhibitors of PSMA.
Public/Granted literature
- US20170296683A1 TRIAZINE BASED RADIOPHARMACEUTICALS AND RADIOIMAGING AGENTS Public/Granted day:2017-10-19
Information query
